Source:

Press Release

Disclosures: Eldrup-Jorgensen reports no relevant financial disclosures.
June 18, 2022
1 min read
Save

CMS approves expanded coverage of TCAR for standard surgical risk patients

Source:

Press Release

Disclosures: Eldrup-Jorgensen reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The Society for Vascular Surgery announced CMS expanded coverage for transcarotid artery revascularization to include standard surgical risk patients within its Vascular Quality Initiative TCAR Surveillance Project.

According to a press release from the SVS, the expanded approval is effective as of May 31, 2022.

“The new coverage decision will allow providers to offer TCAR to all patients who they feel would benefit from the TCAR approach,” Jens Eldrup-Jorgensen, MD, medical director of the Vascular Quality Initiative, professor of surgery at Tufts University School of Medicine and director of the Vascular Center at Maine Medical Center in Portland, said in the release. “Therefore, the choice of intervention will be dependent on provider and patient preference and will not be limited by predefined criteria for coverage.”

Hospitals and physicians participating in the TCAR Surveillance Project can obtain reimbursement for TCAR procedures by submitting claims under the National Clinical Trial number, NCT02850588, according to the release.